Skip to main content
placeholder image

Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?

Journal Article


Abstract


  • This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.

Publication Date


  • 2017

Citation


  • Rehman, A., Yelf, E., Pearson, J., & Yeo, W. (2017). Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?. Internal Medicine Journal, 47(4), 458-461. doi:10.1111/imj.13387

Scopus Eid


  • 2-s2.0-85017284505

Start Page


  • 458

End Page


  • 461

Volume


  • 47

Issue


  • 4

Abstract


  • This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.

Publication Date


  • 2017

Citation


  • Rehman, A., Yelf, E., Pearson, J., & Yeo, W. (2017). Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?. Internal Medicine Journal, 47(4), 458-461. doi:10.1111/imj.13387

Scopus Eid


  • 2-s2.0-85017284505

Start Page


  • 458

End Page


  • 461

Volume


  • 47

Issue


  • 4